Where to buy Pralsetinib

Pralsetinib (Pralsetinib) is an anticancer drug also known as BLU-667. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs). Platinib is mainly used to treat a specific type of cancer, namely RET fusion-positive tumors, such as non-small cell lung cancer (NSCLC), thyroid cancer, etc. It is usually used as an oral drug once a day.

RET gene mutation is one of the common mutations in many cancers, including thyroid cancer, lung cancer, and breast cancer. Platinib works by blocking the action of a natural substance that may be necessary to help cancer cells reproduce, inhibiting RET protein activation, blocking the growth and spread of cancer cells, thereby slowing the progression of cancer. Approval of platinib is based on the percentage of patients whose tumors shrink or disappear after treatment and the duration of this response. Ongoing studies have confirmed the benefits of platinib.

It is understood that the original drug Platinib has been launched in China, but it has not yet entered the scope of medical insurance. The price of each box of 100mg*120 tablets may be around 60,000 yuan. This drug may be sold in domestic hospitals or pharmacies, but the high price may increase the financial burden of some families. The price of the European version of 100mg*60 capsules sold overseas may be around 40,000 yuan per box, and the price of the American version may be around 150,000 yuan per box (prices may fluctuate due to exchange rates). The ingredients of domestic and foreign original drugs are basically the same. There is currently no generic version of Platinib available on the market. Please consult your medical consultant for specific prices and drug details.